IDDI (international drug development institute), a Swiss service provider in the field of biostatistics, is launching a new solution that enables the statistical monitoring of clinical data to detect the heterogeneity of this data, as well as errors and potential fraud.
A strong name, CluePoints emphasizes the idea of detection based on undeniable evidence and facts, while subtly invoking the image of a detective.
